1.
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak
2.
The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium
Seroprevalence of Borrelia burgdorferi in Belgian forestry workers and associated risk factors.
3.
4.
Individual and environmental factors associated with the seroprevalence of Borrelia burgdorferi in Belgian farmers and veterinarians
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility.
Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.
T cell and Antibody Response after two Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Time trend of clinical cases of Lyme disease in two hospitals in Belgium, 2000–2013